Compelling evidence for a prostate cancer gene at 22q12.3 by the international consortium for prostate cancer genetics

Nicola J. Camp, Lisa A. Cannon-Albright, James M. Farnham, Agnes B. Baffoe-Bonnie, Asha George, Isaac Powell, Joan E. Bailey-Wilson, John D. Carpten, Graham G. Giles, John L. Hopper, Gianluca Severi, Dallas R. English, William D. Foulkes, Lovise Maehle, Pal Moller, Ros Eeles, Douglas Easton, Michael D. Badzioch, Alice S. Whittemore, Ingrid Oakley-GirvanChih Lin Hsieh, Latchezar Dimitrov, Jianfeng Xu, Janet L. Stanford, Bo Johanneson, Kerry Deutsch, Laura McIntosh, Elaine A. Ostrander, Kathleen E. Wiley, Sarah D. Isaacs, Patrick C. Walsh, Stephen N. Thibodeau, Shannon K. McDonnell, Scott Hebbring, Daniel J. Schaid, Ethan M. Lange, Kathleen A. Cooney, Teuvo L.J. Tammela, Johanna Schleutker, Thomas Paiss, Christiane Maier, Henrik Grönberg, Fredrik Wiklund, Monica Emanuelsson, William B. Isaacs

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Compelling evidence for a prostate cancer gene at 22q12.3 by the international consortium for prostate cancer genetics'. Together they form a unique fingerprint.

Medicine & Life Sciences